Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1996004908) PHARMACEUTICAL FORMULATION CONTAINING AMOXYCILLIN AND POTASSIUM CLAVULANATE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1996/004908 International Application No.: PCT/EP1995/003151
Publication Date: 22.02.1996 International Filing Date: 08.08.1995
Chapter 2 Demand Filed: 22.02.1996
IPC:
A61K 9/20 (2006.01) ,A61K 31/43 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
425
Thiazoles
429
condensed with heterocyclic ring systems
43
Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula , e.g. penicillins, penems
Applicants:
SMITHKLINE BEECHAM PLC [GB/GB]; New Horizons Court Brendford Middlesex TW8 9EP, GB (AllExceptUS)
RIVETT, Ernest, Lionel, Gilbert [GB/GB]; GB (UsOnly)
GRIMMETT, Francis, Walter [GB/GB]; GB (UsOnly)
HARTNELL, Michael, William [GB/GB]; GB (UsOnly)
Inventors:
RIVETT, Ernest, Lionel, Gilbert; GB
GRIMMETT, Francis, Walter; GB
HARTNELL, Michael, William; GB
Agent:
WALKER, Ralph, Francis; SmithKline Beecham Corporate Intellectual Property SB House, Great West Road Brentford, Middlesex TW8 9BD, GB
Priority Data:
9416600.617.08.1994GB
Title (EN) PHARMACEUTICAL FORMULATION CONTAINING AMOXYCILLIN AND POTASSIUM CLAVULANATE
(FR) COMPOSITION PHARMACEUTIQUE CONTENANT DE L'AMOXYCILLINE ET DU CLAVULANATE DE POTASSIUM
Abstract:
(EN) Pharmaceutical formulations for oral administration, comprising a matrix which comprises a $g(b)-lactam antibiotic optionally in combination with a $g(b)-lactamase inhibitor, granules in a delayed release form dispersed within the matrix, which comprise a $g(b)-lactam antibiotic optionally in combination with a $g(b)-lactamase inhibitor, the overall tablet formulation including a $g(b)-lactam antibiotic and a $g(b)-lactamase inhibitor.
(FR) L'invention concerne des compositions pharmaceutiques destinées à être administrées par voies orales, comprenant une matrice constituée d'une $g(b)-lactamine éventuellement combinée avec un inhibiteur de $g(b)-lactamase, matrice dans laquelle sont dispersées des granules à libération retardée, qui contiennent une $g(b)-lactamine éventuellement combinée avec un inhibiteur de $g(b)-lactamase, la composition globale d'un tel comprimé comprenant une $g(b)-lactamine et un inhibiteur de $g(b)-lactamase.
Designated States: JP, US
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: English (EN)
Filing Language: English (EN)